Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ...
Forbes This study showed that there were 16.0 deaths per patient-year in the metformin- sulfonylurea group versus 7.3 for the metformin-DPP-4 group. Clearly, in the TTD population, the older, better known sulfonylureas did not fare as well as the newer class ... and more »
Family Practice News Digital Network BARCELONA – It's taken 15 years, but newly released data are finally clearing the last shadow of doubt over metformin's safety in type 2 diabetes. Patients in the groundbreaking U.K. Prospective Diabetes Study (UKPDS) who took the drug along with a ...
MarketWatch (press release) Bristol-Myersreported that patients treated with dapagliflozin 10 mg as an add-on therapy to metformin plus sulfonylurea demonstrated significant improvements in glycosylated hemoglobin levels (HbA1c) and, among key secondary endpoints, significant ... and more »
Zenopa The trial examined the performance of dapagliflozin in the treatment of adult patients with type 2 diabetes who were inadequately controlled on combination treatment with metformin plus sulfonylurea . It was found that the therapy, when used as an add ...
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ...
Family Practice News Digital Network BARCELONA – It's taken 15 years, but newly released data are finally clearing the last shadow of doubt over metformin's safety in type 2 diabetes. Patients in the groundbreaking U.K. Prospective Diabetes Study (UKPDS) who took the drug along with a ...
Diabetes Health (press release) According to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with metformin and sulfonylurea . The drug, already available in Europe, is produced by Bristol-Myers ...
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ... and more »
Family Practice News Digital Network BARCELONA – It's taken 15 years, but newly released data are finally clearing the last shadow of doubt over metformin's safety in type 2 diabetes. Patients in the groundbreaking U.K. Prospective Diabetes Study (UKPDS) who took the drug along with a ...
